Learn About Impotence, AIDS, penile implants, vasectomy, prostate cancer and other Sex-Related Health Issues
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Prostate Screening Under Fire

Ivanhoe Broadcast News

(Ivanhoe Newswire) Finding cancers early is a good thing, right? Usually, yes. But when it comes to prostate cancer, researchers are now suggesting some cancers might be better left unknown.

In a review of two large studies on prostate cancer screening with the PSA blood test, investigators from the American Cancer Society and University of Texas Health Science Center at San Antonio note while screening is picking up more cancers, many of those cancers are clinically insignificant.

Advertisement
Related Stories
 border=
To Not Sleep, Perchance to Shorten Your Life
U.S. Pediatricians Decry Media's Portrayal of Sex
Babies Born Late May Face Small Cerebral Palsy Risk
Related Videos
 border=
How Do I Adhere to My HIV Medications?
How Do I Use a Male and Female Condom?
How Do I Get an HIV Test?
Related Slides
 border=
Penile Implants
Placenta Abruptio
PMS
Related Encyclopedia
 border=
AIDS and HIV Infection
Ankylosing Spondylitis
Baldness

Specifically, they note computer modeling shows 29 percent of prostate cancers diagnosed in whites and 44 percent diagnosed in blacks fall into the over diagnosis category, meaning these men would probably never suffer any ill effects from the cancers.

Writing in an accompanying editorial, fellow investigators agree, citing statistics showing the average American man had an 8.7 percent lifetime risk of being diagnosed with prostate cancer before the PSA test was introduced in the mid-80s. By 2005, that risk doubled to 17 percent. But the risk of death from prostate cancer remained relatively stable the average man had a 2.5 percent lifetime risk of dying from the disease prior to widespread use of the PSA test versus a 3 percent risk in 2005.

Because many prostate cancers will never progress to the deadly stage, and treatment for prostate cancer can have significant adverse effects on men, including incontinence and sexual dysfunction, they suggest men should carefully weigh the value of PSA testing with their doctors.

The real impact and tragedy of prostate cancer screening is the doubling of the lifetime risk of a diagnosis of prostate cancer with little if any decrease in the risk of dying from this disease, they conclude.

SOURCE: CA: A Cancer Journal for Clinicians, published online June 29, 2009



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.


Last updated 7/1/2009 10:00:00 AM



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Sep 3, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Erectile Dysfunction Forum
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: